Bicycle Therapeutics (BCYC) Current Taxes (2018 - 2023)

Bicycle Therapeutics (BCYC) posted Current Taxes of $1.9 million for Q2 2023, down 22.49% on a QoQ basis from $2.5 million in Q1 2023.

Bicycle Therapeutics (BCYC) Current Taxes (2018 - 2023) Analysis & Trends

Bicycle Therapeutics' Current Taxes history runs 5 years deep, the most recent figure standing at $1.9 million for Q2 2023.

Quarterly Current Taxes changed N/A year-over-year to $1.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.9 million (changed N/A YoY) and the FY2022 annual result came in at $970000.0, changed N/A from the prior year.
Current Taxes was $1.9 million for Q2 2023 at Bicycle Therapeutics, down from $2.5 million in the prior quarter.
Across five years, Current Taxes topped out at $2.5 million in Q1 2023 and bottomed at $1000.0 in Q4 2019.
A 4-year average of $803285.7 and a median of $269000.0 in 2019 frame the typical range for Current Taxes.
Peak annual rise in Current Taxes reached 93.33% in 2019, while the deepest fall reached 93.33% in 2019.
Bicycle Therapeutics' Current Taxes stood at $1000.0 in 2019, then jumped by 600.0% to $7000.0 in 2020, then soared by 13757.14% to $970000.0 in 2022, then surged by 96.49% to $1.9 million in 2023.
Business Quant data shows BCYC's Current Taxes at $1.9 million in Q2 2023, $2.5 million in Q1 2023, and $970000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Bicycle Therapeutics	289.88 Mn	289.88 Mn	-	-

Download Data